Fabiola Atzeni
#148,389
Most Influential Person Now
Researcher
Fabiola Atzeni's AcademicInfluence.com Rankings
Fabiola Atzenicomputer-science Degrees
Computer Science
#7629
World Rank
#8031
Historical Rank
Computational Linguistics
#1556
World Rank
#1573
Historical Rank
Machine Learning
#2878
World Rank
#2914
Historical Rank
Artificial Intelligence
#3172
World Rank
#3219
Historical Rank
Download Badge
Computer Science
Fabiola Atzeni's Degrees
- PhD Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Fabiola Atzeni Influential?
(Suggest an Edit or Addition)Fabiola Atzeni's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (2016) (865)
- EULAR revised recommendations for the management of fibromyalgia (2016) (716)
- Osteoarthritis: an overview of the disease and its treatment strategies. (2005) (390)
- The Prevalence of Fibromyalgia in the General Population: A Comparison of the American College of Rheumatology 1990, 2010, and Modified 2010 Classification Criteria (2015) (310)
- From endothelial dysfunction to atherosclerosis. (2010) (298)
- Long-term prognosis and causes of death in systemic lupus erythematosus. (2006) (296)
- Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. (2011) (190)
- Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. (2005) (186)
- Immunogenicity and autoimmunity during anti-TNF therapy. (2013) (174)
- Infections as triggers and complications of systemic lupus erythematosus. (2008) (174)
- A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis. (2019) (174)
- Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine (2013) (172)
- New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis) (2004) (168)
- Cardiac involvement in systemic lupus erythematosus (2003) (165)
- Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients. (2009) (160)
- Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment (2020) (157)
- Is atherosclerosis an autoimmune disease? (2014) (157)
- Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. (2012) (155)
- TNF‐α Antagonist Survival Rate in a Cohort of Rheumatoid Arthritis Patients Observed under Conditions of Standard Clinical Practice (2009) (153)
- Autoimmunity and Anti‐TNF‐α Agents (2005) (145)
- Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. (2009) (144)
- Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study (2005) (143)
- Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia? (2004) (143)
- Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. (2009) (133)
- Cardiovascular involvement in systemic autoimmune diseases. (2009) (131)
- Etiology of fibromyalgia: the possible role of infection and vaccination. (2008) (129)
- Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium (2016) (125)
- Treatment strategy in fibromyalgia syndrome: where are we now? (2008) (125)
- Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti–hepatitis B core antigen positive) with rheumatic diseases (2010) (118)
- How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). (2018) (115)
- TNF-α, rheumatoid arthritis, and heart failure: a rheumatological dilemma (2005) (115)
- RETRACTED: Drug-induced lupus erythematosus (2005) (112)
- HCV infection: pathogenesis, clinical manifestations and therapy. (2008) (112)
- Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal. (2009) (111)
- Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems (2005) (107)
- Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. (2009) (106)
- Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity (2014) (106)
- Environment and systemic lupus erythematosus: An overview (2005) (105)
- Behçet’s disease and cardiovascular involvement (2005) (104)
- Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. (2010) (102)
- Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). (2003) (95)
- Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. (2010) (93)
- Identification of the Clinical Features Distinguishing Psoriatic Arthritis and Fibromyalgia (2012) (92)
- Longterm Retention of Tumor Necrosis Factor-α Inhibitor Therapy in a Large Italian Cohort of Patients with Rheumatoid Arthritis from the GISEA Registry: An Appraisal of Predictors (2012) (91)
- Cardiac involvement in systemic rheumatic diseases: An update. (2010) (91)
- Rheumatic manifestations in inflammatory bowel disease. (2014) (91)
- Different effects of biological drugs in rheumatoid arthritis. (2013) (89)
- Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. (2011) (88)
- Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry. (2010) (85)
- The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases. (2010) (85)
- Role of infectious agents in systemic rheumatic diseases. (2008) (83)
- Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis (2008) (79)
- Fibromyalgia: a critical digest of the recent literature. (2013) (79)
- Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next (2017) (78)
- Increased Neural Sympathetic Activation in Fibromyalgia Syndrome (2006) (77)
- Inflammatory response and the endothelium. (2004) (76)
- Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value (2008) (75)
- Autoimmunity and anti-TNF-alpha agents. (2005) (74)
- The immunomodulatory effects of estrogens (2010) (73)
- Thrombotic Risk Factors In Primary Antiphospholipid Syndrome: A 5-Year Prospective Study (2005) (70)
- Multidisciplinary approach to fibromyalgia: what is the teaching? (2011) (70)
- Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. (2005) (69)
- Efficacy and Safety of Anti-Tumour Necrosis Factor in Elderly Patients with Rheumatoid Arthritis: An Observational Study (2010) (69)
- Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. (2011) (66)
- Tumor necrosis factor-a, biologic agents and cardiovascular risk (2005) (66)
- Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect (2009) (65)
- One year in review 2019: fibromyalgia. (2019) (63)
- TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. (2005) (61)
- Chronic widespread pain: from peripheral to central evolution. (2011) (61)
- Relationship between sympathetic activity and pain intensity in fibromyalgia. (2015) (60)
- Pharmacological treatment of fibromyalgia. (2010) (60)
- Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks (2020) (60)
- The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study (2013) (60)
- Infliximab-induced lupus in Crohn's disease: a case report. (2003) (59)
- Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. (2012) (59)
- Co‐Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia (2017) (58)
- Infections and treatment of patients with rheumatic diseases. (2008) (58)
- Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study (2017) (57)
- Potential target of infliximab in autoimmune and inflammatory diseases. (2007) (56)
- Predicting response to anti-TNF treatment in rheumatoid arthritis patients. (2009) (56)
- Systemic rheumatic diseases: From biological agents to small molecules. (2019) (54)
- Biomarkers in Rheumatoid Arthritis. (2017) (53)
- The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis. (2012) (52)
- Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis (2002) (52)
- Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents. (2019) (52)
- Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review (2018) (52)
- Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registry. (2010) (51)
- Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today? (2010) (51)
- Assessment instruments for patients with fibromyalgia: properties, applications and interpretation. (2009) (51)
- Misdiagnosis in fibromyalgia: a multicentre study. (2011) (51)
- Drug-induced lupus erythematosus. (2011) (50)
- Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. (2008) (50)
- Dysfunctional syndromes and fibromyalgia: a 2012 critical digest. (2012) (49)
- OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. (2007) (49)
- The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review. (2012) (48)
- Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. (2013) (48)
- Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others). (2006) (48)
- Coronary Flow Reserve and Asymmetric Dimethylarginine Levels: New Measurements for Identifying Subclinical Atherosclerosis in Patients with Psoriatic Arthritis (2011) (48)
- Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experience. (2005) (47)
- Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-γ, and IFN-α (2002) (47)
- Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis (2012) (47)
- Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. (2005) (44)
- Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome. (2019) (44)
- Fibromyalgia and nutrition: what news? (2015) (44)
- Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis (2013) (44)
- Polymyositis–dermatomyositis and infections (2006) (43)
- EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome (2022) (43)
- Pain in rheumatoid arthritis: a critical review. (2014) (43)
- Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response (2015) (43)
- Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study (2016) (43)
- Autoantibody production in patients treated with anti-TNF-α (2008) (42)
- Etiopathogenetic mechanisms of fibromyalgia syndrome. (2011) (42)
- Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross‐sectional study (2013) (42)
- Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. (2012) (42)
- Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection (2016) (42)
- EULAR recommendations for management of fibromyalgia (2017) (41)
- Efficacy of ketoprofen vs. ibuprofen and diclofenac: a systematic review of the literature and meta-analysis. (2013) (41)
- Pain and ketoprofen: what is its role in clinical practice? (2011) (41)
- Which kind of exercise is best in fibromyalgia therapeutic programmes? A practical review. (2010) (41)
- New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome: a pilot study. (2014) (40)
- Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. (2009) (40)
- An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis (2003) (40)
- Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis (2005) (40)
- Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3 (2005) (40)
- Switching rheumatoid arthritis treatments: an update. (2011) (39)
- Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis (2013) (39)
- Symptoms and signs in fibromyalgia syndrome. (2011) (39)
- Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study (2020) (39)
- Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN). (2011) (38)
- How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion (2020) (38)
- Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. (2019) (37)
- Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria? (2017) (37)
- Central motor control failure in fibromyalgia: a surface electromyography study (2009) (37)
- Cardiovascular effects of approved drugs for rheumatoid arthritis (2021) (37)
- Long-term safety of abatacept in patients with rheumatoid arthritis. (2013) (36)
- TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same? (2017) (36)
- Is fibromyalgia a discrete entity? (2012) (36)
- Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? (2015) (36)
- Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy. (2005) (36)
- Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study (2020) (35)
- The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis (2017) (35)
- Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. (2005) (35)
- IL-6 INVOLVEMENT IN PAIN, FATIGUE AND MOOD DISORDERS IN RHEUMATOID ARTHRITIS AND THE EFFECTS OF IL-6 INHIBITOR SARILUMAB. (2019) (35)
- Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction (2018) (35)
- Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study (2010) (35)
- Autoantibody profile during short‐term infliximab treatment for Crohn's disease: a prospective cohort study (2005) (35)
- Successful treatment of resistant Behçet's disease with etanercept. (2005) (34)
- Infections in rheumatoid arthritis (2017) (34)
- From autoinflammation to autoimmunity: old and recent findings (2018) (33)
- What is the role of rituximab in the treatment of rheumatoid arthritis? (2007) (33)
- Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha. (2002) (33)
- Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. (2020) (33)
- Cardiac imaging techniques in systemic autoimmune diseases (2005) (32)
- Early treatment in early undifferentiated arthritis. (2012) (32)
- Anti-cytokine antibodies for rheumatic diseases. (2009) (32)
- Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. (2018) (32)
- Interleukin 6 Blockade: Tocilizumab in Psoriatic Arthritis (2012) (31)
- A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac (2018) (30)
- Measuring psoriatic disease in clinical practice. An expert opinion position paper. (2015) (30)
- Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature (2011) (30)
- Pain in fibromyalgia and related conditions. (2014) (29)
- Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies (2015) (29)
- Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study (2019) (29)
- Position paper of Italian rheumatologists on the use of biosimilar drugs. (2015) (29)
- Clinimetric evaluations of patients with chronic widespread pain. (2011) (29)
- Pain and systemic lupus erythematosus. (2014) (29)
- Pain in systemic inflammatory rheumatic diseases. (2015) (29)
- Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry (2017) (28)
- One year in review 2016: fibromyalgia. (2016) (28)
- Significance of serum Il-9 levels in inflammatory bowel disease (2015) (28)
- Tumor necrosis factors blocking agents: analogies and differences. (2012) (28)
- Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA (2018) (28)
- Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. (2014) (28)
- Safety of rituximab in rheumatoid arthritis. (2011) (28)
- Cardiovascular and autoimmune diseases in females: The role of microvasculature and dysfunctional endothelium. (2015) (27)
- The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review (2017) (27)
- AB1096 Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder (2012) (27)
- The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers. (2013) (26)
- Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register (2018) (26)
- Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients (2020) (26)
- Disease Severity in Never Smokers, Ex‐Smokers, and Current Smokers With Axial Spondyloarthritis: Results From the Scotland Registry for Ankylosing Spondylitis (2017) (25)
- Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritis. (2009) (25)
- The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. (2020) (25)
- Cardiovascular involvement in psoriatic arthritis. (2011) (25)
- Skin involvement and outcome measures in systemic autoimmune diseases. (2006) (25)
- OP0006 Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients (2017) (24)
- Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy (2016) (24)
- Preclinical Impairment of Coronary Flow Reserve in Patients with Rheumatoid Arthritis (2007) (24)
- Doctors' Insights into the Patient Perspective: A Qualitative Study in the Field of Chronic Pain (2014) (24)
- Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests. (2014) (23)
- Physiopathology of pain in rheumatology. (2014) (23)
- Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis (2017) (23)
- Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register. (2014) (23)
- Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort (2020) (23)
- Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound. (2020) (23)
- Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins (2015) (22)
- Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review (2019) (21)
- Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. (2017) (21)
- Efficacy and Safety of Leflunomide or Methotrexate plus Subcutaneous Tumour Necrosis Factor-Alpha Blocking Agents in Rheumatoid Arthritis (2011) (21)
- Infections and Biological Therapy in Patients with Rheumatic Diseases. (2016) (21)
- How to measure chronic pain: New concepts. (2015) (21)
- Neuroendocrine therapy of fibromyalgia syndrome: an update (2010) (21)
- Bleomycin-Induced Scleroderma: Report of a Case with a Chronic Course Rather Than the Typical Acute/Subacute Self-Limiting Form (1999) (21)
- CD69 expression on neutrophils from patients with rheumatoid arthritis. (2004) (21)
- Physical and rehabilitative approaches in osteoarthritis. (2004) (21)
- Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease. (2015) (20)
- Localized and systemic forms of scleroderma in adults and children . (2006) (20)
- B Lymphocyte intestinal homing in inflammatory bowel disease (2011) (20)
- Complementary and alternative medicine in fibromyalgia: a practical clinical debate of agreements and contrasts. (2013) (20)
- Chronic widespread pain in the spectrum of rheumatological diseases. (2011) (20)
- Web/Internet-based telemonitoring of a randomized controlled trial evaluating the time-integrated effects of a 24-week multicomponent intervention on key health outcomes in patients with fibromyalgia. (2015) (20)
- Imaging of diffuse idiopathic skeletal hyperostosis (DISH) (2020) (19)
- The clinical impact of Anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature (2017) (19)
- Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab (2016) (19)
- Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. (2020) (19)
- Autoimmune diseases and infections: controversial issues. (2008) (19)
- Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis. (2011) (18)
- A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data. (2015) (18)
- Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from the LORHEN registry (2017) (18)
- Fibromyalgia syndrome: definition and diagnostic aspects. (2011) (18)
- Osteoarthritis of the spine. (2004) (18)
- Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease. (2009) (18)
- Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. (2017) (18)
- A possible link between ankylosing spondylitis and periodontitis: a systematic review and meta-analysis. (2015) (18)
- Medical cannabis and cannabinoids in rheumatology: where are we now? (2019) (17)
- The impact of pain on systemic rheumatic diseases. (2015) (17)
- Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B (2013) (17)
- In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones. (2008) (17)
- CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease. (2012) (16)
- Costs associated with rheumatoid arthritis in Italy: past, present, and future (2016) (16)
- Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study. (2019) (16)
- Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. (2003) (16)
- Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA. (2019) (16)
- Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort (2019) (16)
- The Prevalence Of Fibromyalgia In The General Population - a Comparison Of The ACR 1990, 2010 and Modified 2010 Classification Criteria (2013) (16)
- The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review (2021) (16)
- Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability (2016) (16)
- Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases. (2010) (16)
- Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report (2016) (16)
- Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: A prospective long-term follow-up (2008) (16)
- Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component (2021) (16)
- Pain in systemic connective tissue diseases. (2015) (16)
- Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs. (2017) (15)
- Fibromyalgia syndrome: the pharmacological treatment options. (2011) (15)
- Complementary treatment in fibromyalgia: combination of somatic and abdominal acupuncture. (2012) (15)
- The evaluation of the fibromyalgia patients. (2011) (15)
- Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab. (2010) (15)
- The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptoms. (2004) (15)
- Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study (2020) (15)
- Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases (2015) (15)
- One year in review 2021: fibromyalgia. (2021) (15)
- The words of pain in complex regional pain syndrome. (2015) (15)
- Skin manifestations in vasculitis and erythema nodosum. (2006) (15)
- The Rheumatology Drugs for COVID-19 Management: Which and When? (2021) (15)
- Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves Prioritization (2021) (15)
- The Role of Hyperbaric Oxygen Therapy in Orthopedics and Rheumatological Diseases. (2017) (15)
- Non pharmacological treatments in fibromyalgia. (2008) (14)
- Fibromyalgia position paper. (2021) (14)
- Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series (2018) (14)
- Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors (2018) (14)
- Psoriatic arthritis: from pathogenesis to pharmacologic management. (2019) (13)
- Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database (2020) (13)
- Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis (2012) (13)
- Mycophenolate Mofetil in Lupus Glomerulonephritis (2007) (13)
- The role of echocardiographic techniques in connective tissue diseases. (2005) (13)
- EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASES. (2020) (13)
- Pain modulation in patients with fibromyalgia undergoing acupuncture treatment is associated with fluctuations in serum neuropeptide Y levels. (2017) (13)
- Chronic widespread pain in spondyloarthritis. (2014) (13)
- Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis. (2017) (13)
- AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS) (2019) (12)
- Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification. (2021) (12)
- Takayasu's arteritis overlapping with systemic sclerosis. (1999) (12)
- Editorial: Fibromyalgia: A Never‐Ending Story of Central and Peripheral Pain Mechanisms (2014) (12)
- The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference. (2018) (12)
- Rheumatic diseases and autoimmune vascular dementia. (2017) (12)
- [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome]. (2003) (12)
- Fibromyalgia and arthritides. (2012) (12)
- Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia. (2011) (12)
- Hepatotropic viruses: new insights in pathogenesis and treatment. (2008) (12)
- Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity (2019) (12)
- Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjogren Syndrome : Analysis of 9302 Patients from the Big Data International Sjogren Cohort (2017) (11)
- [Early rheumatoid arthritis]. (2011) (11)
- An update on emerging drugs for fibromyalgia treatment (2017) (11)
- Feet nailfold capillaroscopy is not useful to detect the typical scleroderma pattern. (2012) (11)
- Resistant Cases of Psoriatic Arthritis: How to Manage Them (2009) (11)
- Chronic widespread pain or fibromyalgia? That is the question. (2011) (11)
- Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? (2021) (11)
- Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies. (2020) (11)
- Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts (2015) (10)
- Concerns about the safety of anti-TNF agents when treating rheumatic diseases (2020) (10)
- Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art (2019) (10)
- Comparison of Efficacy of Ketoprofen and Ibuprofen in Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis (2021) (10)
- No Correlations Between the Development of Specific IgA and IgM Antibodies Against Anti-TNF Blocking Agents, Disease Activity and Adverse Side Reactions in Patients with Rheumatoid Arthritis (2013) (10)
- Behçet disease: From pathogenesis to novel therapeutic options. (2021) (10)
- SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients (2020) (10)
- Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy (2021) (10)
- FRI0255 The 158vv fcgamma receptor 3a genotype is associated with response to rituximab in rheumatoid arthritis: results of an italian multicentre study (2013) (10)
- Measurement of Serum Klotho in Systemic Sclerosis (2017) (10)
- The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses (2017) (10)
- Efficacy of a comprehensive rehabilitation programme combined with pharmacological treatment in reducing pain in a group of OA patients on a waiting list for total joint replacement. (2012) (10)
- The Neuropathic Pain Features in Psoriatic Arthritis: A Cross-sectional Evaluation of Prevalence and Associated Factors (2019) (10)
- Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol (2005) (10)
- The safety of pregabalin in the treatment of fibromyalgia (2016) (10)
- Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis (2015) (9)
- Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance. (2018) (9)
- A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory Arthritis. (2017) (9)
- Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography. (2019) (9)
- Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis (2019) (9)
- HIV/AIDS: epidemic update, new treatment strategies and impact on autoimmunity. (2008) (9)
- Costs of pain in rheumatology. (2014) (9)
- Childhood adversities in patients with fibromyalgia: are they related to comorbid lifetime major depression? (2017) (9)
- Twelve years’ experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practice (2012) (9)
- Features of mood associated with high body weight in females with fibromyalgia. (2018) (9)
- Usefulness of six-minute walk test in systemic sclerosis. (2018) (9)
- Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's disease. (2009) (9)
- Anti-polymer antibodies are inversely correlated with pain and fatigue severity in patients with fibromyalgia syndrome (2008) (9)
- Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients. (2019) (9)
- Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry (2014) (9)
- Novel pharmaceutical options for treating fibromyalgia (2016) (9)
- Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients. (2020) (9)
- Gruppo Italiano di Studio sulle Early Arthritides (GISEA). Longtermretention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal ofpredictors. (2012) (8)
- Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group. (2021) (8)
- TLR-4 and VEGF Polymorphisms in Chronic Periaortitis (2013) (8)
- One year in review : fibromyalgia (2016) (8)
- 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases (2022) (8)
- Acute and chronic pain in orthopaedic and rheumatologic diseases: mechanisms and characteristics. (2017) (8)
- What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? (2016) (8)
- Pain management in cryoglobulinaemic syndrome. (2015) (8)
- From Mitchell's causalgia to complex regional pain syndromes: 150 years of definitions and theories. (2015) (8)
- The therapeutic approach to complex regional pain syndrome: light and shade. (2015) (8)
- Increase of sympathetic outflow measured by NPY and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with SLE and RA – Another example of uncoupling of response systems (2005) (8)
- Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases (2018) (8)
- Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries. (2017) (8)
- CARDIOVASCULAR CONSEQUENCES OF AUTOIMMUNE RHEUMATIC DISEASES. (2020) (8)
- Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system. (2020) (8)
- Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain (2021) (8)
- Pain in systemic sclerosis. (2014) (7)
- Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) (2020) (7)
- AB0297 Dose reduction in patients with rheumatoid arthritis responding to the standard rituximab regimen. (2013) (7)
- New biological treatments for psoriatic arthritis. (2014) (7)
- Rituximab treatment for Sjogren syndrome-associated non-Hodgkin’s lymphoma: case series (2012) (7)
- Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study. (2020) (7)
- Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis (2021) (7)
- Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study (2019) (7)
- Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment (2019) (7)
- C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis. (2022) (7)
- Differences between diffuse idiopathic skeletal hyperostosis and spondyloarthritis. (2020) (7)
- Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies? (2019) (7)
- The contribution of HERV‐E clone 4‐1 and other HERV‐E members to the pathogenesis of rheumatic autoimmune diseases (2020) (7)
- THU0320 New Parameters for Identifying Subclinical Atherosclerosis in Patients with Primary SjöGren’s Syndrome: A Pilot Study (2013) (6)
- Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study. (2016) (6)
- Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium. (2021) (6)
- Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes. (2019) (6)
- Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure. (2018) (6)
- SERUM CALPROTECTIN LEVELS AS A MARKER OF ARTHRITIS: AN ITALIAN EXPERIENCE. (2016) (6)
- Tumor Necrosis Factor (2013) (6)
- Severe bitter taste associated with apremilast (2019) (6)
- Biomarkers predictors of good EULAR response to B cell depletion therapy (BCDT) in seropositive Rheumatoid Arthritis patients (2010) (6)
- Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results. (2013) (6)
- Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy (2021) (6)
- Biosimilars vs originators: Are they the same? (2019) (6)
- Anti‐TNF therapy restores the hypothalamic‐pituitary‐adrenal axis (2010) (6)
- The effect of drugs used in rheumatology for treating SARS-CoV2 infection (2020) (6)
- Cannabis and Autoimmunity: Possible Mechanisms of Action (2021) (6)
- Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications (2021) (6)
- Controlled-release pregabalin in the treatment of fibromyalgia (2018) (5)
- The association between body mass index and fibromyalgia severity: data from a cross-sectional survey of 2339 patients (2021) (5)
- Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis. (2005) (5)
- Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases. (2020) (5)
- THU0232 Golimumab Therapy Retention Rates in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthritis: Data from the Italian Lorhen Registry (2015) (5)
- Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data. (2021) (5)
- Pain in fibromyalgia syndrome (2002) (5)
- Thyroid acropachy: an unusual rheumatic manifestation of Graves' disease. (2005) (5)
- Unilateral polymyalgia rheumatica with controlateral sympathetic dystrophy syndrome. A case of asymmetrical involvement due to pre-existing peripheral palsy. (2006) (5)
- Strategies for Early Identification of Atherosclerosis in Systemic AutoimmuneDisease (2014) (5)
- Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead‐based FACS CANTO II cytometers (2018) (5)
- Granulomatosis polyangiitis associated with meningeal involvement: response to rituximab therapy after failure of cyclophosphamide. (2013) (5)
- Unusual B cell morphology in inflammatory bowel disease. (2012) (5)
- Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies. (2022) (5)
- Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium (2022) (5)
- Adult-onset Still's disease with elderly onset, results from a multicentre study. (2021) (5)
- Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjögren's syndrome? (2017) (5)
- [Pharmacological treatment of fibromyalgia]. (2007) (5)
- Lack of association of the -463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients. (2007) (5)
- Rheumatoid arthritis: Why wait? Explaining delays in seeking therapy for early arthritis (2012) (5)
- Polymorphic alleles in exon 1 of the CTLA4 gene do not predict the response to abatacept. (2013) (5)
- Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method: the Italian experience. (2012) (5)
- Cardiovascular injury in systemic autoimmune diseases: an update (2011) (5)
- The therapeutic journey of biologic agents: There will be an end? (2019) (4)
- Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? (2020) (4)
- Fibromyalgia syndrome: preventive, social and economic aspects. (2011) (4)
- Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease (2022) (4)
- Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events (2022) (4)
- From Old to New Cardiovascular Complications in Ankylosing Spondylitis. (2017) (4)
- [Cardiac involvement in rheumatoid arthritis]. (2011) (4)
- Toll-like receptor 4 ( TLR 4 ) gene polymorphisms in Italian patients with Behçet ’ s disease (2006) (4)
- Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years. (2015) (4)
- Do Anti-TNF Blockers Increase the Risk of Lung Involvement in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? A Systematic Review. (2016) (4)
- Fibromyalgia syndrome: still a medical dilemma. (2012) (4)
- Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures (2021) (4)
- Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis? (2015) (4)
- PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease. (2011) (4)
- Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment. (2014) (4)
- Morphological distribution of μ chains and cd15 receptors in colorectal polyp and adenocarcinoma specimens (2013) (4)
- Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports (2019) (4)
- Rationale underlying the measurement of fractional exhaled nitric oxide in systemic sclerosis patients. (2019) (4)
- DIFFERENCES IN DEPRESSION, ANXIETY AND STRESS DISORDERS BETWEEN FIBROMYALGIA ASSOCIATED WITH RHEUMATOID ARTHRITIS AND PRIMARY FIBROMYALGIA. (2020) (4)
- Possible relationship between certolizumab pegol and arrhythmias: report of two cases. (2016) (4)
- Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy. (2017) (4)
- [Alveolar hemorrhage in pulmonary-renal syndrome anti-SCL/70 and anti-MPO-ANCA positive]. (2009) (4)
- Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis (2018) (3)
- Cardiovascular Involvement in Sjögren’s Syndrome (2022) (3)
- Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis. (2020) (3)
- Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone. (2015) (3)
- Conventional and Biological DMARDs in Systemic Rheumatic Diseases: Perioperative Risk/Benefit Management (2018) (3)
- Is panic disorder associated with clinical severity of fibromyalgia? A preliminary study in a tertiary-care centre. (2016) (3)
- FRI0149 Fifteen Years of Biological Treatment for Rheumatoid Arthritis: Data from the Italian Lorhen Registry (2015) (3)
- Diffusing Pulmonary Capacity Measured During Effort: A Possible Early Marker of Pulmonary Involvement In Systemic Sclerosis. (2015) (3)
- Anti‐tumour necrosis factor‐&agr; antibodies and B cell homeostasis in human inflammatory bowel diseases (2018) (3)
- Do patients with ankylosing spondylitis have an excess prevalence of chronic widespread pain?: Results from the Scotland and Ireland Registry for Ankylosing Spondylitis (SIRAS) and the MUSICIAN study (2013) (3)
- OP0089 Big Data Sjögren Project (Eular-SS Task Force International Network): Characterization at Diagnosis of 5027 Patients with Primary Sjögren Syndrome (2015) (3)
- Psoriatic Arthritis Registries (2015) (3)
- FRI0174 Two-Year Retention Rate of Subcutaneous Anti-Tumor Necrosis Factor Agents for Rheumatoid Arthritis: A Retrospective Analysis of The Lorhen Registry (2016) (3)
- Algo-dysfunctional syndromes: a critical digest of the recent literature. (2015) (3)
- Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study (2020) (3)
- Neurophysiological background for physical therapies in fibromyalgia. (2012) (3)
- Pain in rheumatic diseases: how relevant is it? (2014) (3)
- The role of klotho in systemic sclerosis. (2017) (2)
- FRI0419 Big Data Sjogren Project (Eular-SS Task Force International Network): Systemic Involvement at Diagnosis Evaluated by the Essdai in 3314 Patients with Primary Sjögren Syndrome (2015) (2)
- PLA 1 / A 2 polymorphism of platelet glycoprotein receptors IIIa in Behçet ’ s disease (2006) (2)
- The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts. (2018) (2)
- Frequency of Renal Function Parameter Abnormalities in Patients with Psoriatic Arthritis and Rheumatoid Arthritis: Real-World Evidence from Clinical Practice (2022) (2)
- Antigen Preparation for Immunological Studies in Systemic Autoimmune Diseases (2007) (2)
- Safety of ketoprofen compared with ibuprofen and diclofenac: A systematic review and meta-analysis (2014) (2)
- The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome (2020) (2)
- International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia. (2022) (2)
- Chapter 8 – Cardiac Imaging Techniques in Systemic Autoimmune Diseases (2017) (2)
- Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study (2021) (2)
- Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study". (2018) (2)
- Autoimmunity and the newer biopharmaceuticals (2007) (2)
- OP0120 Influence of epidemiology and ethnicity on systemic expression of primary sjÖgren syndrome in 9974 patients (2018) (2)
- Somatoform disorders and rheumatic diseases: from DSM-IV to DSM-V. (2014) (2)
- Therapeutic peptides for the treatment of systemic lupus erythematosus: a place in therapy (2020) (2)
- Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs? (2021) (2)
- Use of Ultrasonography in Patients with Inflammatory Bowel Disease and Spondyloarthritis: An Update (2012) (2)
- Infections during treatment with biological agents and possible treatment in clinical practice (2013) (2)
- The Heart in Systemic Autoimmune Diseases (2017) (2)
- Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort (2022) (2)
- SAT0585 Evaluation of Wikipedia Rheumatology Articles as A Learning Resource for Medical Students (2014) (2)
- Chapter 27 Modulation of Hormone Axes by Anti-TNF Therapy (2008) (2)
- Subclinical Cardiovascular Involvement in Autoimmune Diseases: Role ofCoronary Flow Reserve (2014) (2)
- Impaired lung transfer factor in fibromyalgia syndrome. (2016) (1)
- Diagnosis and management of cardiovascular risk in rheumatoid arthritis: main challenges and research agenda (2023) (1)
- THU0164 Subclinical atherosclerosis and cardiovascular events in italian patients with rheumatoid arthritis: results from multicenter girrcs (gruppo italiano di ricerca in reumatologia clinica e sperimentale) study (2017) (1)
- THE EFFECT OF SMOKING CESSATION IN ANKYLOSING SPONDYLITIS: RESULTS FROM THE SCOTLAND REGISTRY FOR ANKYLOSING SPONDYLITIS (SIRAS) (2014) (1)
- WITHDRAWN: Abatacept as a first-line biological therapy. (2013) (1)
- Chapter 92 – Autoimmunity and the Newer Biopharmaceuticals (2014) (1)
- Toxicological considerations in the treatment of axial spondylo-arthritis (2020) (1)
- Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry. (2022) (1)
- THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease (2017) (1)
- FRI0232 Factors Influencing The Choice of First and Second Line Biologic Therapy for The Treatment of Rheumatoid Arthritis: Real Life Data from The Italian Lorhen Registry (2016) (1)
- AB0429 The Role of TH9 Lymphocytes in Rheumatoid Arthritis (2015) (1)
- IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment? (2022) (1)
- SAT0620 Potential role of metacarpophalangeal joints ultrasound in the differential diagnosis between early rheumatoid arthritis and early spondyloarthritis (2017) (1)
- AB0568 Can Speckle Tracking Echocardiography Dectect Left Subclinal Ventricular Dysfunction in Patients with Primary Sjogren Syndrome? (2015) (1)
- Psoriatic arthritis (2010) (1)
- [Frequency and clinical associations of antineutrophil cytoplasmic antibodies. A regional experience]. (2010) (1)
- Comment on: Diagnosis of fibromyalgia: comparison of the 2011/2016 ACR and AAPT criteria and validation of the modified Fibromyalgia Assessment Status. Reply. (2020) (1)
- ISPE MidYear 2021 (2021) (1)
- FRI0114 Efficacy and retention rate of certolizumab pegol in rheumatoid arthritis: data from a large real-life multicentre retrospective cohort (2018) (1)
- Diagnostic and therapeutic care pathway for fibromyalgia. (2021) (1)
- Recurrent intracranial hemorrhage and cerebral venous sinus thrombosis: an atypical case of Neuro-Behçet’s Syndrome (2020) (1)
- Corrigendum to “Measuring psoriatic disease in clinical practice. An expert opinion position paper” [Autoimmun. Rev. 14/10 (2015) p.864–874] (2016) (1)
- Basic (PS01–PS58) (2012) (1)
- AB0493 Efficacy of Ketoprofen vs Ibuprofen for Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis (2015) (1)
- Corrigendum to “Clinical and laboratory aspects of Ro/SSA-52 autoantibodies” [J. Autoimmun. Rev.10 (2011) 150-154] (2012) (1)
- FRI0175 Anti-drug-antibodies but not igg-4 antibodies against tnf blockers influence the activity of anti-tnf drugs in rheumatoid arthritis (2013) (1)
- Incidence du cancer chez les patients atteints de spondyloarthrite traités par anti-TNF (2017) (1)
- THU0349 A Double-Blind, Randomised, Parallel Group, Active Controlled, Multicentre Study to Assess the Therapeutic Non-Inferiority of Skp-021, A 0.3% Ketoprofen Patch, versus Diclofenac Sodium Patch in Patients with Acute Inflammatory Musculoskeletal Injuries (2014) (1)
- Anti-TNF antibody therapy does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increased androstenedione relative to cortisol (2005) (1)
- Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities (2022) (1)
- Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis. (2019) (1)
- Hyperbaric oxygen treatment of fibromyalgia : a prospective observational clinical trial (2019) (1)
- Systemic Sjögren presenting without sicca syndrome : characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria (2018) (1)
- AB0635 Measurement of Serum Alpha-Klotho in Systemic Sclerosis Patients: Results from A Pivotal Study (2016) (1)
- Rapid development of unmasking disseminated tuberculosis-related immune reconstitution inflammatory syndrome in a young HIV-infected patient after starting combination antiretroviral therapy (2018) (1)
- FRI0215 Comparative efficacy and retention rate of tocilizumab and tnf inhibitors used in combination with methotrexate as first-line biologic therapy in rheumatoid arthritis: data from a multicentre observational registry (2017) (1)
- OP0126 LYMPHOMA ARISING AT THE TIME OF DIAGNOSIS OF PRIMARY SJÖGREN SYNDROME: A HIGHLY-ACTIVE SYSTEMIC SUBSET OF THE DISEASE (2019) (1)
- Publisher Correction: Cardiovascular effects of approved drugs for rheumatoid arthritis (2021) (1)
- Anti-PTX3: are they real? (2008) (1)
- Big Data International Primary Sjogren Syndrome Registry : Baseline Characterization and Diagnostic Approach in 6047 Patients Fulfilling the 2002 AE Criteria (2015) (1)
- Analysis of the association of CDA (Cytidin Deaminase) (K27Q), TNF alfa (-308G>A) and PTPN22 R620W genetic polymorphisms with autoantibody seropositive RA and the response to B cell depletion (2010) (1)
- Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry (2015) (1)
- SAT0219 Prevalence of Chronic Widespread Pain in SSC Patients: Preliminary Data (2013) (1)
- Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? (2019) (1)
- FRI0432 CLINICAL EXAMINATION AND ULTRASOUND IN THE ASSESSMENT OF PATIENTS WITH PSORIATIC ARTHRITIS WITH AND WITHOUT FIBROMYALGIA (2019) (1)
- [Complementary medicine in rheumatoid arthritis]. (2011) (1)
- OP0090 THE OCCURRENCE OF SUBCLINICAL AND CLINICAL ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS, RESULTS FROM THE 3-YEAR, MULTICENTER, PROSPECTIVE, OBSERVATIONAL, GIRRCS STUDY (2019) (1)
- Update on fibromyalgia (2012) (1)
- Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne (2017) (1)
- Protein Z G 79 A and A13 G gene polymorphisms in Italian patients with Behçet ’ s disease (2006) (1)
- Reply to: mast cells in fibromyalgia. (2015) (1)
- SAT0092 CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: AN ITALIAN RHEUMATOLOGISTS’ SURVEY (2020) (1)
- AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea (2018) (1)
- Artrite reumatoide all’esordio = Early rheumatoid arthritis (2007) (1)
- AB0681 Can Conventional and Non-Conventional Cardiovascular Markers Identify Different Types of Cardiovascular Involvement in Ankylosing Spondylitis and Psoriatic Arthritis (2016) (0)
- SAT0167 Clinical and Ultrasonographic Evaluation in A Cohort of Sustained Remission Rheumatoid Arthritis Patients after Stopping Biologic Therapy: A Single Center Experience (2014) (0)
- FRI0182 Comorbidities Influence the Choice of the Biologic Agent: Real Life Data from the Lorhen Registry (2015) (0)
- Autoimmune hepatitis and allergic reactions during anti-TNFα treatment. (2015) (0)
- Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey (2022) (0)
- AB1068 Pain, fatigue and functional impairment in fibromyalgia patients may be riduced by adding a cycle of hyperbaric oxygen therapy (HBOT) treatment (2018) (0)
- Fibromyalgia syndrome: definition and diagnostic aspects La sindrome fibromialgica: definizione ed aspetti diagnostici (2008) (0)
- Poster Session 4: Friday 9 December 2011, 14:00-18:00 * Location: Poster Area (2011) (0)
- IN PATIENTS WITH SPONDYLOARTHRITIS ANTI-TNF THERAPY IS NOT ASSOCIATED WITH AN INCREASE IN NEOPLASIAS: RESULTS OF GISEA REGISTER (2016) (0)
- Correlation between carotid intima-media thickness, ADMA and coronary flow reserve in rheumatoid arthtritis (2009) (0)
- SAT0457 SjÖgren big data project, the first example of data sharing in autoimmune diseases: analysis of 10475 worldwide patients (2018) (0)
- THU0238 Ultrasonographic evaluation of distal patellar enthesis in patients affected by entheropatic spondiloarthritis (2018) (0)
- Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases (2021) (0)
- New Cardiac Imaging Tools and Invasive Techniques in Systemic Autoimmune Diseases (Part II) (2017) (0)
- Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks (2020) (0)
- Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virus (2023) (0)
- Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response (2015) (0)
- Esistono markers per definire il rischio cardiovascolare nei pazienti affetti da artrite reumatoide? Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients? (2009) (0)
- SAT0596 Ultrasonographic Evaluation of Subclinicial Enthesitis in Patients Affected by Pediatric Inflammatory Bowel Disease (2015) (0)
- AB0860 A New Safety Meta-Analysis of Ketoprofen VS Ibuprofen and Diclofenac: Risk and Benefit of NON Steroidal Anti-Inflammatory Drugs beyond Efficacy Meta-Analysis (2014) (0)
- JAK inhibitors: special issue foreword (2022) (0)
- THU0319 Determination of the Serological Profiles in Anti-Ro-52-Positive Patients with Systemic Autoimmune Rheumatic Diseases. (2013) (0)
- THU0257 ESTIMATED 10-YEARS CARDIOVASCULAR RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS FROM THE “CARDIOVASCULAR OBESITY AND RHEUMATIC DISEASE (CORDIS)” STUDY GROUP OF THE ITALIAN SOCIETY OF RHEUMATOLOGY. (2020) (0)
- AB0313 Factors predicting disability in patients affected by long-standing rheumatoid arthritis treated with anti-TNF drugs: An observational study (2013) (0)
- List of Contributors (2019) (0)
- AB1195 FIBROMYALGIA AND SOCIODEMOGRAPHIC FACTORS: DATA FROM THE ITALIAN FIBROMYALGIA REGISTRY (2022) (0)
- Clinical and immunological disease patterns of primary Sjogren syndrome driven by gender and age at diagnosis (2018) (0)
- OA08 JAK inhibitors and the risk of malignancy: a meta-analysis across licenced disease indications (2023) (0)
- [Do we have markers to define the cardiovascular risk -in rheumatoid arthritis patients?]. (2011) (0)
- [Anti-PR3 positive inflammatory bowel disease. Description of a case]. (2009) (0)
- Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D, inflammation and activity (2018) (0)
- AB0541 Relationship Between Ultrasonographic Salivary Glands Abnormalities and Subclinical Cardiovascular Involvement in Patients with Primary SjÖgren Syndrome (2015) (0)
- Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (2015) (0)
- Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia. (2023) (0)
- Pyogenic arthritis of the facet joints: a growing problem for patients, a growing concern for clinicians. (2006) (0)
- SAT0327 Baseline characteristics and reasons for apremilast prescription in a large italian cohort of psoriatic arthritis patients (2018) (0)
- AB0693 Diffusing Pulmonary Capacity (DLCO) Measured During Effort May be an Early Marker of Pulmonary Involvement in Systemic Sclerosis (2015) (0)
- Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study (2023) (0)
- Psychiatricproblemsinfibromyalgia: clinicalandneurobiologicallinksbetween mooddisordersandfibromyalgia (2012) (0)
- How ethnicity modifies systemic activity of primary Sjögren syndrome : analysis of baseline ESSDAI scores in a multi-ethnic international cohort (2018) (0)
- Erratum to "What is the role of rituximab in the treatment of rheumatoid arthritis?" [Journal of Autoimmunity Reviews 6 (8) (2007) 553-558] (2010) (0)
- Silent impairment of coronary microcirculation in rheumatoid arthritis (2005) (0)
- Fibromyalgia syndrome: the pharmacological tre atment options Il trattamento farmacologico della sindrome fibromialgica (2008) (0)
- CC chemokine receptor 5 polymorphism in Italian patients with Behc¸et’s disease RHEUMATOLOGY (2012) (0)
- THU0205 Cardiovascular Evaluation Using Non-Invasive Imaging Methods in Patients with Ankylosing Spondylitis Before and After 12 Months of Treatment with anti-TNF Drugs (2015) (0)
- [B-cell depletion and primary Sjögren's syndrome: is there a role for rituximab?]. (2011) (0)
- A self-tracking tool for detecting chronic widespread pain in axial spondyloarthritis. (2023) (0)
- Cross Cultural Adaptation andValidation of ItalianVersion of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain (2021) (0)
- Reviewer acknowledgment (2016) (0)
- AB0505 Risk and Benefit Profile of Nsaids: A New Overall Analysis on Efficacy and Safety of Ketoprofen vs Ibuprofen and Diclofenac (2015) (0)
- Evidence for a genetic contribution to the ossification of spinal ligaments in Ossification of Posterior Longitudinal Ligament and Diffuse idiopathic skeletal hyperostosis: A narrative review (2022) (0)
- FRI0072 Predictors of response to anti-TNF therapy in ra patients with moderate disease activity compared to those with high disease activity according to DAS28 scores’ (2013) (0)
- Cardiovascular Risk in Systemic Inflammatory Arthritis (2023) (0)
- How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model (2018) (0)
- The Functional Syndromes as Fibromyalgia Comorbidities (2021) (0)
- THU0113 Predictive factors of response to rituximab therapy modify the accelerated atherosclerosis in patients with rheumatoid arthritis (2013) (0)
- The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod. (2022) (0)
- SAT0683 A north-south worldwide gradient in systemic activity of primary sjÖgren syndrome: increased severe disease in patients from southern countries (2018) (0)
- Building bridges between doctors and patients: the design and pilot evaluation of a training session in argumentation for chronic pain experts (2015) (0)
- FRI0143 Influence of low-dose glucocorticoid treatment on persistence on biologic dmards therapy: real-life data from the italian gisea registry (2018) (0)
- Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study (2016) (0)
- Effect of biological DMARDs and JAK inhibitors in pain of chronic inflammatory arthritis (2022) (0)
- [Serological and clinical aspects in initial Wegener's disease. A case report]. (2010) (0)
- From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” (2023) (0)
- SAT0302 Analysis of 9302 patients from the big data international primary sjÖgren syndrome cohort: clinical presentation at diagnosis of european vs non-european patients (2017) (0)
- Neurobiological similarities between RA and fibromyalgia (2018) (0)
- Vasculitis 265. Cryoglobulinemic Vasculitis Secondary to Hepatitis C Infection: Is Prediction of Disease Severity Feasible? (2011) (0)
- CASE REPORT Takayasu ' s arteritis overlapping with systemic sclerosis / (2006) (0)
- AB0143 EXPRESSION OF HERV-E CLONE 4.1 GAG TRANSCRIPTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS (2020) (0)
- THU0366 Gastrointestinal infections in patients with spondyloarthritis treated with anti-tnf drugs: results of gisea register (2017) (0)
- Subclinical cardiac involvement in early rheumatoid arthritis detected by speckle tracking echocardiography (2009) (0)
- THU0352 Worldwide Heterogeneous Diagnostic Approach To Primary Sjögren Syndrome in 8315 Patients (EULAR-SS Task Force Big Data Sjögren Project) (2016) (0)
- FRI0053 Comparison of the Risk of Developing Comorbities and Adverse Events by Type of Diagnosis: Results from the Lorhen Registry (2014) (0)
- POS0214 ASSOCIATION BETWEEN C-REACTIVE PROTEIN AND 10-YEAR RISK OF CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS USING THE ERS-RA SCORE: A CROSS-SECTIONAL ANALYSIS OF THE CORDIS COHORT (2021) (0)
- Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society of Rheumatology. (2022) (0)
- Correction to: Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study (2022) (0)
- THU0349 Assessment of dry eye symptoms in primary fbromyalgia (2013) (0)
- SAT0152 Polymyalgia Rheumatica: A Comparative Study of Methylprednisolone and the Modified Release Prednisone (2013) (0)
- AB0427 Clinical and laboratory findings in patients with late-onset sle and correlations with il6 concentrations (2013) (0)
- Helicobacter pylori Infection and Gastric Autoimmunity (2015) (0)
- Echocardiographic approach in systemic autoimmune diseases (2011) (0)
- AB0332 Golimumab Efficacy in Rheumatoid Arthritis after Conventional and Biological Treatment: Data from The Italian Lorhen Registry (2016) (0)
- AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) (2019) (0)
- SAT0309 Reduced Pulmonary Diffusion Capacity May BE an Early Indicator of Exercise-Induced Desaturation in Systemic Sclerosis Patients with Ild (2014) (0)
- AB0862 An ultrasonographic study on entheseal involvement in asymptomatic patients with inflammatory bowel disease with or without spondyloarthritis (2013) (0)
- Interstitial lung disease and rheumatoid arthritis (2022) (0)
- Rheumatoid Arthritis and the Skin (2006) (0)
- THU0156 Impact of Verification Bias on the Evaluation of Diagnostic Accuracy of Lung Ultrasound in Rheumatoid Arthritis-Related Related Interstitial Lung Disease (2015) (0)
- Biologics and Biosimilars (2019) (0)
- Metabolic Syndrome in Systemic Sclerosis Patients: Data from Clinical Practice. (2021) (0)
- AB0191 Sdai as predictor of 1-year efficacy of the first tnf blocker in clinical practice. (2013) (0)
- SAT0223 Predictive factors of early failure to first line treatment with methotrexate in patients with rheumatoid arthritis. results from the gisea registry. (2018) (0)
- More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment (2022) (0)
- Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry (2021) (0)
- Full-length manuscript The neuropathic pain features in Psoriatic Arthritis: a cross-sectional evaluation of prevalence and associated factors Running head: Neuropatic pain in PsA Authors and affiliations: (2019) (0)
- Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis (2011) (0)
- CC chemokine receptor 5 polymorphism in Italian patients with Behc¸et’s disease (2012) (0)
- AB0682 Correlation between Disease Activity and Cardiovascular Parameters in Patients with Ankylosing Spondylitis (2016) (0)
- The evaluation of the fibromyalgia patients La valutazione del paziente fibromialgico (2008) (0)
- The Relevance of Preoperative Education Among Healthcare Providers, Family Caregivers, and Patients With Systemic Rheumatic Diseases (2018) (0)
- Pain in system ic connective tissue diseases Best Practice & Research Clin ical Rh eum atology (2015) (0)
- Clinical and Immunological Characterization at Diagnosis of 5041 Patients with Primary Sjogren Syndrome Fulfilling the 2002 AE Classification Criteria: The Big Data International Sjogren Project (2015) (0)
- Preclinical atherosclerosis at the onset of psoriatic arthritis (2009) (0)
- Rheumatoid arthritis and vascular dementia : do they have common pathogenetic mechanisms ? (2015) (0)
- OP0310 GENDER AND FIBROMYALGIA SEVERITY: REAL LIFE DATA FROM THE ITALIAN REGISTRY (2021) (0)
- Th9 lymphocytes in rheumatoid arthritis (2014) (0)
- AB0343 Myocardial involvement in patients with rheumatoid arthritis evaluated by two-dimensional speckle tracking echocardiography before and after 18 months of treatment with anti-tnf drugs (2018) (0)
- AB0311 The 158vv fcgamma receptor iiia genotype predicts a positive response to rituximab in rheumatoid arthritis: Analysis in a large cohort of italian patients (2013) (0)
- Pain in systemic connective tissue diseases Best Practice & Research Clinical Rheumatology (0)
- Study of entheses in patients with spondyloarthritis and inflammatory bowel disease with and without fibromyalgia: The importance of ultrasonography. (2020) (0)
- Conference Scene: Report on the Second International Congress on Controversies in Rheumatology & Autoimmunity (2013) (0)
- Bone and joint bacterial infections in patients with rheumatoid arthritis (2020) (0)
- AB0797 Impairment of coronary microcirculation in patients with diffuse systemic sclerosis (2013) (0)
- Failure of unicondylar knee replacement in a patient with psoriatic arthropathy (2005) (0)
- POS0634 SAFETY PROFILE OF b/tsDMARD IN RHEUMATOID ARTHRITIS PATIENTS WITH IMPAIRED GLOMERULAR FILTRATION RATE. AN ANALYSIS FROM THE GISEA REGISTRY. (2022) (0)
- Early psoriatic arthritis: should we treat it in the same way as we treat rheumatoid arthritis? (2015) (0)
- THU0455 DIFFERENCES IN PSYCHIATRIC COMORBIDITIES AND LIFE ADVERSITIES BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH FIBROMYALGIA AND PATIENTS WITH PRIMARY FIBROMYALGIA (2020) (0)
- AB0011 Evaluation of salivary mirnas in patients affected by sjÖgren’s syndrome and correlation with clinical and ultrasonographic outcomes (2018) (0)
- Autoimmunity induced by adalimumab during rheumatoid arthritis treatment (2004) (0)
- THU0127 Estimated cardiovascular risk in a large cohort of rheumatoid arthritis patients from the “Cardiovascular Obesity and Rheumatic DISease (CORDIS)” Study Group of the Italian Society of Rheumatology. (2020) (0)
- THU0277 HOW THE AGE AT DIAGNOSIS MODIFIES THE PHENOTYPE OF PRIMARY SJÖGREN SYNDROME: ANALYSIS IN 11,420 PATIENTS (BIG DATA SJÖGREN PROJECT) (2019) (0)
- Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN) = Efficacia e sicurezza degli agenti anti-TNF nel registro Lombardo (LORHEN) (2008) (0)
- AB0035 Paradoxical Expansion of Th1 and TH17 Cells in Peripheral Cultural Blood Cells of RA Patients following Infliximab Treatment: A Possible Correlation with Loss of Clinical Response and Adverse Events (2014) (0)
- Preclinical impairment of coronary flow reserve evaluated by transthoracic echocardiography in patients with rheumatoid arthritis (2007) (0)
- [Low back pain and fibromyalgia syndrome]. (2006) (0)
- , G . Madeddu Multiple brain and pulmonary abscesses due to Streptomyces spp . in a patient with silicosis (2018) (0)
- Spondyloarthritis and Gastrointestinal Involvement (2017) (0)
- Can Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis? (2015) (0)
- AB0689 Metabolic syndrome in ankylosing spondylitis and the effect of anti-tnf therapy (2017) (0)
- BTT_A_209873 13..21 (2020) (0)
- AB0716 FIBROMYALGIA SYNDROME SEVERITY ACCORDING TO AGE CATEGORIES: RESULTS FROM A NATIONAL REGISTER (2021) (0)
- Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area (2013) (0)
- Reply: To PMID 22899452. (2013) (0)
- Immunoglobulin M Distribution and Modular Peptide Interactions in the Stroma of Human Colorectal Adenomas and Adenocarcinomas (2017) (0)
- Symptoms and signs in fibromyalgia syndrome [I segni e i sintomi della sindrome fibromialgica] (2007) (0)
- C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients. (2023) (0)
- Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” (2022) (0)
- Lymphocyte, monocyte, endothelial activation in early rheumatoid arthritis patients (2007) (0)
- Diagnosis of cardiac involvement in systemic autoimmune diseases (2007) (0)
- Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database. (2021) (0)
- Dr. Marchesoni and Dr. Atzeni reply (2012) (0)
- Etiopathogenetic mechanisms of fibromyalgia syndrome Meccanismi eziopatogenetici della sindrome fibromialgica (2008) (0)
- Rheumatoid Arthritis from Easy to Complex Disease: From the “2022 GISEA International Symposium” (2023) (0)
- OP0180 TLR4 and VEGF polymorphisms in chronic periaortitis (2013) (0)
- Fibromyalgia: who should reshape the pain perception of these patients? (2008) (0)
- Extra-intestinal manifestations in inflammatory bowel disease (2020) (0)
- Differential Diagnosis of Vasovagal Syncope: Fibromyalgia (2015) (0)
- Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages. (2023) (0)
- AB0222 Body Mass Index, Smoking Status and Response To Rituximab in Rheumatoid Arthritis: A Real Life Study (2016) (0)
- THU0284 Predicting survival in 6240 patients with primary sjÖgren' syndrome (big data sjÖgren project) (2017) (0)
- Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group (2023) (0)
- THU0544 Impaired Pulmonary Diffusing Capacity in Patients with Fibromyalgia (2016) (0)
- THU0150 INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS). (2020) (0)
- SAT0287 Ethnic Differences Strongly Influence The Phenotypic Expression of Primary Sjögren: Study of 7887 Patients from 20 Countries on 5 Continents (EULAR-SS Task Force Big Data Sjögren Project) (2016) (0)
- AB1106 PREVALENCE AND EPIDEMIOLOGY OF FAMILIAL MEDITERRANEAN FEVER AND TUMOR NECROSIS FACTORRECEPTOR-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM AN ITALIAN CENTER (2019) (0)
- Reply (2013) (0)
- Fibromyalgia syndrome: preventive, social and economic aspects Gli aspetti preventivi, sociali ed economici della sindrome fibromialgica (2008) (0)
- Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) (0)
- Prédicteurs de la réponse aux traitements anti-TNF chez les patients ayant une polyarthrite rhumatoïde avec des scores DAS28 modérés ou élevés☆ (2014) (0)
- 858 Transoesophageal echocardiographic study in 50 patients affected by rheumatoid arthritis (2003) (0)
- Characterization of Baseline Systemic Activity Using the New ClinESSDAI in the Big Data Sjogren Project Cohort: Analysis in 3316 Patients (2015) (0)
- Anti-TNF Therapy Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry (2015) (0)
- Poster Session II (2009) (0)
- SAT0144 Meta-Analysis of the Relationship between Rheumatoid Arthritis, Lung Disease and Biological and Non-Biological Drugs (2014) (0)
- Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study. (2022) (0)
- Onset and temporal sequencing patterns of comorbidity between lifetime major depression, panic disorder and fibromyalgia. (2022) (0)
- Reactivation of occult hepatitis B virus infection under treatment with abatacept: a case report (2016) (0)
- Antibody profiles in patients treated with tumor necrosis factor-alpha antagonists: new findings (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Fabiola Atzeni?
Fabiola Atzeni is affiliated with the following schools:
